Meeting
2014 Gastrointestinal Cancers Symposium
Preoperative radiotherapy combined with simultaneous chemotherapy with capecitabine plus oxaliplatin versus surgery alone: A single-centered, phase II study in patients with mid/low rectal cancer.
Authors
Fulong Wang
State Key Laboratory of Oncology in South China; Sun Yat-Sen University Cancer Center, Guangzhou, China
Fulong Wang , Zhen-Hai Lu , Zhizhong PAN , Yuan-Hong Gao , Gong Chen , Xiaojun Wu , Pei-Rong Ding , Zhi-Fan Zeng , Desen Wan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Cancers of the Colon and Rectum
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
ChiCTR-TRC-00000122
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 609)
DOI
10.1200/jco.2014.32.3_suppl.609
Abstract #
609
Poster Bd #
D58
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
A phase II study of chemotherapy and immune checkpoint blockade with pembrolizumab in the perioperative and maintenance treatment of locoregional gastric or GE junction adenocarcinoma.
First Author: Paul Eliezer Oberstein
Poster
2015 ASCO Annual Meeting
A phase II single arm feasibility trial of neoadjuvant chemotherapy (NAC) with oxaliplatin/fluorouracil (OxMdG) then short-course preoperative radiotherapy (SCPRT) then immediate surgery in operable rectal cancer (ORC): COPERNICUS (NCT01263171).
First Author: Simon Gollins
Poster
2011 ASCO Annual Meeting
Efficacy endpoints of RTOG 0247: A randomized phase II study of neoadjuvant capecitabine (C) and irinotecan (I) or C and oxaliplatin (O) with concurrent radiation therapy (RT) for locally advanced rectal cancer.
First Author: S. J. Wong
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Combination of hSTC810 and capecitabine therapy in metastatic colorectal cancer with resistance or intolerance to oxaliplatin and irinotecan-based chemotherapy: A single arm, phase 1b/2, multicenter study.
First Author: Jiwon Lee